https://www.acplgroupindia.in
91

10.As provided in the rules, surrogate marker should be considered as an interim data poin...

View more

After the NDA is accepted the various section of the application should undergo concurrent...

View more

3. As per the rules, for manufacture or import of new drugs, the manufacturers/ importer a...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

Sugam builds a comprehensive database of the various permissions and licenses issued by S...

View more

15.However, detailed guidance documents should be prepared providing the requirements and ...

View more

5. Clear policy on regulatory requirements, system and procedures is critical for efficien...

View more

Further CDSCO along with state regulators, is jointly responsible for grant of licenses of...

View more

POLICY ON POST-APPROVAL STUDIES 1. Post-approval studies may be required to provide additi...

View more

Subscribe for latest offers and updates.

we hate spam too